ghk-cu long-term use tolerance desensitization ghk cu receptor downregulation long term The Human Tripeptide in Prevention ghk-cu tolerance desensitization effectiveness over

(2008) described the discovery and characterization of the tissue-protective EPO receptor (now called the innate repair receptor) and demonstrated that engineered EPO derivatives lacking erythropoietic activity retained cytoprotective signaling, laying the foundation for ARA-290 development [2]

Conventional L-amino acid peptides are rapidly degraded by proteases (half-life of minutes in biological fluids)

This maintenance phase is key to keeping the benefits from the first phase

By stimulating growth factors and improving blood flow, it supports faster recovery from injuries and surgeries

Primary applications: wound healing (closure kinetics, collagen organization, tensile strength), tendon and ligament regeneration (Achilles transection, biomechanical testing), gastroprotection (NSAID protection, mucosal barrier, fistula healing), angiogenesis (HUVEC tube formation, VEGF expression, CAM assays), neuroprotection (gut-brain axis, neuroinflammatory reduction), and inflammation studies (cytokine modulation, ERK1/2 pathway)